EMA Highlights: First-in-class treatment to lower cholesterol
by Gary Finnegan: Patients whose high cholesterol cannot be controlled by currently available therapies are set to have a new treatment option.
by Gary Finnegan: Patients whose high cholesterol cannot be controlled by currently available therapies are set to have a new treatment option.
by Gary Finnegan: Survival rates in young patients with high-risk neuroblastoma can be improved by Unituxin (dinutuximab), a new treatment approved by the European Medicines Agency (EMA).
Research published today in the journal Analyst has demonstrated a new, noninvasive test that can detect cocaine use through a simple fingerprint. For the first time, this new… read more.
by Gary Finnegan: Canada could save $7.3 billion annually with universal public coverage of medically necessary prescription drugs, according to new research from the University of British Columbia… read more.
by Gary Finnegan: Five new medicines have been recommended for approval at the latest meeting of the European Medicines Agency’s Committee for Medicinal Products for Human Use
by Gary Finnegan: The European Medicines Agency (EMA) has reduced the fees it charges to companies who hold – or apply for – marketing authorisation for medicines.
by Gary Finnegan: Medicines watchdogs on both sides of the Atlantic could significantly step up collaboration if a new transatlantic trade deal is sewn up later this year.
by Bruce Sylvester: Researchers report that a combination morphine and nortriptyline successfully relieves chronic neuropathic pain in 87 per cent of patients, and the efficacy of the combination… read more.
by Bruce Sylvester: Paracetamol is not effective for treating neck and lower back pain, and it provides only slight relief for osteoarthritis, researchers reported on March 31, 2015… read more.
Medicine obviously can’t do much good if it sits on a pharmacy shelf. Yet more than one-quarter of the acne patients surveyed by researchers didn’t get medications prescribed… read more.
by Bruce Sylvester: Researchers report that treating post-tonsillectomy pain with morphine can cause some children to develop life-threatening respiratory problems. The study also showed that ibuprofen is a… read more.
by Gary Finnegan: The number of new medicines for rare diseases approved by EU drug regulators hit a record high in 2014. Of the 82 medicines given the… read more.
Advertisment